Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 -0.0566037735849057 -0.0566037735849057
Stock impact report

Polydex Pharmaceuticals Issues Second Quarter Financial Results

POLYDEX PHARMS LTD (POLXF) 
US:NASDAQ Investor Relations: polydex.com
Company Research Source: GlobeNewswire
TORONTO, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (Pink Sheets:POLXF) (the “Company”) is pleased to report financial results for the second  quarter of fiscal 2020, the period ending July 31, 2019.  All figures are reported in U.S. dollars.  Q2 ending July 31, 2019Q2 ending July 31, 2018   Sales1,243,8831,267,481   Net Income119,89460,149   Income per common share  - basic0.040.02                                             - diluted0.030.02   Weighted avg. common shares  Outstanding  - basic3,419,4783,419,478 Show less Read more
Impact Snapshot
Event Time:
POLXF
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for POLXF alerts
Opt-in for
POLXF alerts

from News Quantified
Opt-in for
POLXF alerts

from News Quantified